📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
94 announcements match the current filters (relevance ≥ 5).
Clean Science Declares ₹2 Interim Dividend; Q3 Revenue Grows 12% YoY to ₹218.5 Cr
Clean Science and Technology reported a 12.2% YoY growth in consolidated revenue from operations, reaching ₹2,185.5 million for Q3 FY26. However, consolidated net profit saw a decline of approximately 11% YoY, coming in at ₹459.3 million compared to ₹516.1 million in the same quarter last year. The Board has declared an interim dividend of ₹2 per share (200% of face value) with a record date of February 6, 2026. The decline in profit despite revenue growth suggests pressure on margins or increased operational costs during the period.
Key Highlights
Consolidated Revenue from Operations grew 12.2% YoY to ₹2,185.5 million in Q3 FY26.
Consolidated Net Profit decreased by 11% YoY to ₹459.3 million from ₹516.1 million.
Declared an interim dividend of ₹2 per equity share (200% on face value of ₹1).
Record date for dividend eligibility is February 6, 2026, with payment by February 23, 2026.
Consolidated EPS for the quarter declined to ₹4.32 from ₹4.86 in the year-ago period.
👀 What to Watch
Investors should monitor the margin compression as net profit fell despite double-digit revenue growth. While the dividend provides a yield, the bottom-line performance suggests rising input or operational costs that need further investigation.
Clean Science Declares ₹2 Interim Dividend; Q3 PAT Declines to ₹45.8 Crore
Clean Science and Technology has announced an interim dividend of ₹2 per share (200% of face value) for FY 2025-26, with the record date set for February 6, 2026. The company's consolidated revenue for Q3 FY26 stood at ₹249.6 crore, showing growth over the ₹194.7 crore reported in the same quarter last year. However, net profit saw a decline to ₹45.8 crore from ₹56.7 crore YoY and ₹65.7 crore sequentially. The dividend payment is scheduled to be completed by February 23, 2026.
Key Highlights
Interim dividend of ₹2 per equity share of face value ₹1 each
Consolidated Revenue from operations at ₹2,496.4 million for Q3 FY26
Consolidated Net Profit (PAT) fell to ₹458.3 million vs ₹567.5 million YoY
Basic EPS for the quarter decreased to ₹4.32 from ₹5.35 YoY
Record date for dividend eligibility is February 6, 2026
👀 What to Watch
Investors seeking the dividend must hold shares before the February 6 record date. While the dividend is a positive payout, the sequential and year-on-year decline in profitability suggests monitoring margin pressures in the specialty chemicals segment.
Clean Science Q3 FY26: Revenue Falls 9% YoY; Interim Dividend of ₹2 Declared
Clean Science and Technology reported a weak Q3 FY26 with consolidated revenue declining 9% YoY to ₹219 crore and PAT dropping 30% YoY to ₹46 crore. EBITDA margins faced significant pressure, contracting to 33.4% from 41.5% in the year-ago period. Despite the slowdown, the company commercialized new capacities for Hydroquinone and Catechol and declared an interim dividend of ₹2 per share. The Performance Chemicals segment now contributes 76% of total revenue, driven by growth in the HALS series.
Key Highlights
Consolidated Q3 FY26 Revenue at ₹219 crore, down 9% YoY and 11% QoQ.
Consolidated PAT for the quarter stood at ₹46 crore, a 30% decline compared to Q3 FY25.
EBITDA margins compressed to 33.4% in Q3 FY26 from 41.5% in Q3 FY25 and 36.4% in Q2 FY26.
Incurred ₹165 crore capex in 9M FY26, primarily for the Clean Fino Chem Ltd (CFCL) subsidiary.
Successfully commercialized Hydroquinone and Catechol capacities during Q3 FY26.
👀 What to Watch
Investors should exercise caution as profitability margins have significantly compressed despite new product launches. Monitor the utilization rates of the newly commercialized Hydroquinone and Catechol plants for signs of recovery in the coming quarters.
Clean Science Declares ₹2 Interim Dividend; Q3 Net Profit Rises 25.5% YoY to ₹45.8 Cr
Clean Science and Technology reported a robust performance for Q3 FY2025-26, with consolidated revenue growing 28.2% YoY to ₹249.6 crore. Net profit for the quarter increased by 25.5% to ₹45.8 crore, up from ₹36.5 crore in the previous year. Alongside the earnings, the board declared an interim dividend of ₹2 per share (200% of face value). The company maintains a healthy balance sheet with an EPS improvement to ₹4.32 for the quarter.
Key Highlights
Declared interim dividend of ₹2 per equity share (200%) with a record date of February 6, 2026
Consolidated Revenue from operations rose 28.2% YoY to ₹2,496.14 million
Consolidated Net Profit (PAT) increased 25.5% YoY to ₹458.41 million
Basic and Diluted EPS improved to ₹4.32 from ₹3.44 in the corresponding quarter last year
Nine-month consolidated PAT stands at ₹1,211.12 million on a revenue of ₹6,769.30 million
👀 What to Watch
The combination of double-digit growth and a steady dividend payout reflects strong operational efficiency. Investors should hold for long-term gains while monitoring the record date of February 6 for dividend eligibility.
Clean Science Q3 FY26 Results: Consolidated Revenue Up 28%, Declares ₹2 Interim Dividend
Clean Science and Technology reported a 28% year-on-year growth in consolidated revenue from operations, reaching ₹2,496.44 million for Q3 FY26. However, consolidated net profit declined significantly to ₹458.41 million from ₹633.29 million in the previous year's corresponding quarter, indicating margin pressure. On a standalone basis, the company maintained stability with a net profit of ₹651.25 million. To reward shareholders, the board declared an interim dividend of ₹2 per share (200% of face value) with a record date of February 6, 2026.
Key Highlights
Consolidated Revenue from Operations rose 28% YoY to ₹2,496.44 million in Q3 FY26.
Consolidated Net Profit fell to ₹458.41 million compared to ₹633.29 million in Q3 FY25.
Declared an interim dividend of ₹2 per equity share (200%) for the financial year 2025-26.
Standalone Net Profit remained steady at ₹651.25 million versus ₹630.48 million YoY.
The record date for dividend eligibility is February 6, 2026, with payment scheduled by February 23, 2026.
👀 What to Watch
Investors should investigate the cause of the sharp decline in consolidated profit despite strong revenue growth, focusing on subsidiary performance and raw material costs. While the dividend is positive, the margin compression warrants a cautious approach until cost-efficiency improves.
Clean Science Invests ₹50 Crore in Subsidiary Clean Fino-Chem for Project Funding
Clean Science and Technology Limited (CSTL) has invested ₹50 crore in its wholly-owned subsidiary, Clean Fino-Chem Limited (CFCL), via a rights issue. The investment involved subscribing to 8,36,121 equity shares at a price of ₹598 per share (including a ₹588 premium). CFCL is a specialty chemicals manufacturer that has shown rapid growth, with turnover increasing from ₹1.92 crore in FY24 to ₹46.77 crore in FY25. This capital infusion is specifically earmarked to fund ongoing projects, indicating a focus on capacity expansion.
Key Highlights
Investment of ₹50.00 crore in wholly-owned subsidiary Clean Fino-Chem Limited.
Acquisition of 8,36,121 equity shares at ₹598 per share (₹10 face value + ₹588 premium).
CFCL turnover grew significantly from ₹1.92 crore in FY24 to ₹46.77 crore in FY25.
Capital will be utilized primarily for funding specialty chemical projects within the subsidiary.
👀 What to Watch
Investors should monitor the execution of CFCL's projects as the subsidiary is scaling rapidly and becoming a meaningful contributor to consolidated revenue. The continued investment signals management's confidence in the specialty chemicals growth pipeline.
Clean Science Subsidiary Commences Commercial Production of Hydroquinone and Catechol
Clean Science and Technology's wholly-owned subsidiary, Clean Fino-Chem Limited, has officially started commercial production of Hydroquinone (HQ) and Catechol as of December 18, 2025. This expansion positions the company as a significant domestic manufacturer, aiming to capture market share through import substitution. The production of HQ is strategically designed to create cross-selling opportunities with existing MEHQ customers and enhance the company's TBHQ market presence. Furthermore, Catechol will be used for captive consumption in the manufacturing of Guaiacol and Veratrole, improving vertical integration.
Key Highlights
Commenced commercial production of Hydroquinone and Catechol on December 18, 2025
Aims to become a key domestic manufacturer to drive import substitution in specialty chemicals
HQ production creates cross-selling opportunities with MEHQ customers and strengthens TBHQ market share
Catechol will be captively consumed for the production of Guaiacol and Veratrole
Project highlights robust in-house R&D and synergistic project engineering capabilities
👀 What to Watch
Investors should view this as a significant growth milestone that enhances vertical integration and market reach. Monitor the revenue contribution from these new lines in the upcoming quarterly results to assess the speed of market penetration.
Clean Science Appoints Siddhartha Sikchi as MD; Ashok Boob as Vice Chairman Effective April 2026
Clean Science and Technology Limited has received shareholder approval for a significant leadership transition effective April 1, 2026. Mr. Siddhartha Ashok Sikchi will take over as Managing Director for a five-year term, while the current MD, Mr. Ashok Ramnarayan Boob, will transition to the role of Executive Vice Chairman. Additionally, the company secured approval for the appointment and re-appointment of four Independent Directors, ensuring board stability. These resolutions were passed via postal ballot with over 99% of votes in favor for most items, indicating strong shareholder support for the succession plan.
Key Highlights
Mr. Siddhartha Ashok Sikchi appointed as Managing Director for a 5-year term starting April 1, 2026.
Current MD Mr. Ashok Ramnarayan Boob to transition to Executive Vice Chairman role from April 2026 to July 2027.
Four Independent Directors (Madhu Dubhashi, Keval Doshi, Raj Kamal, Pallavi Gokhale) appointed or re-appointed to the board.
Resolutions passed with high majority; for instance, the MD appointment received over 99.9% approval from voting members.
👀 What to Watch
This is a planned leadership transition within the promoter group, suggesting continuity in corporate strategy and operational philosophy. Investors should monitor the transition in 2026, but the move is currently viewed as a routine and stable succession process.
Clean Science Shareholders Approve Leadership Transition; Siddhartha Sikchi to be MD from April 2026
Clean Science and Technology Limited has received shareholder approval for a significant leadership transition effective April 1, 2026. Mr. Siddhartha Ashok Sikchi will take over as Managing Director for a five-year term, while the current MD, Mr. Ashok Ramnarayan Boob, will transition to the role of Executive Vice Chairman. Additionally, the company secured approvals for the appointment and re-appointment of four Independent Directors, ensuring board stability and regulatory compliance through 2030-2031.
Key Highlights
Mr. Siddhartha Ashok Sikchi appointed as Managing Director for a 5-year term starting April 1, 2026.
Current MD Mr. Ashok Ramnarayan Boob to transition to Executive Vice Chairman from April 2026 to July 2027.
Re-appointment of Mr. Keval Navinchandra Doshi as Independent Director for 5 years approved with 99.46% votes.
New Independent Directors Mr. Raj Kamal and Ms. Pallavi Gokhale appointed for 5-year terms starting November 2025.
Resolution to continue Ms. Madhu Dubhashi's directorship past age 75 passed with 99.92% majority.
👀 What to Watch
The planned leadership transition indicates strong succession planning and reduces management uncertainty. Investors should maintain their positions as the core leadership remains involved in the company's strategic direction.
Clean Science Shareholders Approve Leadership Transition and New Director Appointments
Clean Science and Technology Limited has received shareholder approval for a significant leadership transition and board restructuring. Mr. Siddhartha Ashok Sikchi will be elevated to Managing Director for a five-year term starting April 1, 2026, while the current MD, Mr. Ashok Ramnarayan Boob, will transition to Executive Vice Chairman. Additionally, the company confirmed the appointment of two new Independent Directors, Mr. Raj Kamal and Ms. Pallavi Gokhale, for five-year terms. These resolutions were passed via postal ballot with over 99% approval in most cases, indicating strong institutional and promoter support.
Key Highlights
Mr. Siddhartha Ashok Sikchi appointed as Managing Director for a 5-year term effective April 1, 2026.
Mr. Ashok Ramnarayan Boob to transition to Executive Vice Chairman from April 2026 to July 2027.
Appointment of two new Independent Directors, Mr. Raj Kamal and Ms. Pallavi Gokhale, for 5-year terms starting November 2025.
Re-appointment of Mr. Keval Navinchandra Doshi as Independent Director for a second 5-year term until February 2031.
All resolutions passed with requisite majority, with institutional favor exceeding 98% for key appointments.
👀 What to Watch
Investors should take confidence in the structured succession plan and the strengthening of independent board oversight. No immediate action is necessary as the primary executive changes are scheduled for 2026, ensuring a smooth transition period.
Clean Science Shareholders Approve New MD and Board Appointments for 5-Year Terms
Clean Science and Technology Limited has received shareholder approval via postal ballot for several key leadership transitions. Mr. Siddhartha Ashok Sikchi will take over as Managing Director for a five-year term starting April 1, 2026, while Mr. Ashok Ramnarayan Boob moves to the role of Executive Vice Chairman. The board also adds Mr. Raj Kamal and Ms. Pallavi Gokhale as Independent Directors for five-year tenures. These appointments, along with the re-appointment of Mr. Keval Doshi, reflect a structured approach to governance and succession planning.
Key Highlights
Mr. Siddhartha Ashok Sikchi appointed as Managing Director for a 5-year term effective April 1, 2026.
Mr. Raj Kamal and Ms. Pallavi Gokhale join as Independent Directors for 5-year terms starting Nov 6, 2025.
Mr. Ashok Ramnarayan Boob to serve as Executive Vice Chairman from April 2026 to July 2027.
Resolution for Mr. Raj Kamal's appointment passed with significant majority through postal ballot e-voting.
Mr. Keval Navinchandra Doshi re-appointed as Independent Director for a second 5-year term until 2031.
👀 What to Watch
Investors should note the planned leadership transition in 2026 as a sign of stable succession planning. No immediate action is required as the changes maintain governance continuity.
Clean Science Approves MD Succession and Re-appointment of Independent Directors
Clean Science and Technology Limited has announced the approval of several key leadership transitions via postal ballot. Mr. Siddhartha Ashok Sikchi will take over as Managing Director for a 5-year term starting April 1, 2026, while current MD Mr. Ashok Ramnarayan Boob will transition to Executive Vice Chairman. Shareholders also approved the re-appointment of Mr. Keval Navinchandra Doshi as an Independent Director for another 5-year term starting February 2026. These resolutions were passed with high majorities, with the re-appointment of Mr. Doshi receiving 99.46% favorable votes.
Key Highlights
Mr. Siddhartha Ashok Sikchi appointed as Managing Director for a 5-year term effective April 1, 2026.
Mr. Ashok Ramnarayan Boob to transition to Whole Time Director - Executive Vice Chairman from April 1, 2026.
Mr. Keval Navinchandra Doshi re-appointed as Independent Director for 5 years (2026-2031) with 99.46% approval.
New Independent Directors Mr. Raj Kamal and Ms. Pallavi Gokhale appointed for 5-year terms starting November 2025.
Total of 84.38 million votes polled across resolutions, reflecting strong shareholder participation.
👀 What to Watch
Investors should view the clear succession planning and the retention of founding members in strategic roles as a sign of long-term stability. No immediate action is required as the primary leadership transition is scheduled for 2026.
Clean Science Shareholders Approve Leadership Transition; Siddhartha Sikchi Named MD from April 2026
Clean Science and Technology Limited has received shareholder approval for a significant leadership transition and several board appointments. Mr. Siddhartha Ashok Sikchi will take over as Managing Director for a five-year term starting April 1, 2026, while the current MD, Mr. Ashok Ramnarayan Boob, will transition to Executive Vice Chairman. Additionally, the company secured approvals for the appointment and re-appointment of four Independent Directors for five-year terms. These resolutions were passed with overwhelming majorities, with total valid votes cast reaching approximately 84.38 million.
Key Highlights
Siddhartha Ashok Sikchi appointed as Managing Director for a 5-year term effective April 1, 2026.
Current MD Ashok Ramnarayan Boob to transition to Whole Time Director - Executive Vice Chairman from April 1, 2026.
Re-appointment of Keval Navinchandra Doshi as Independent Director for a 5-year term until February 2031.
Appointment of Raj Kamal and Pallavi Gokhale as Independent Directors for 5-year terms starting November 2025.
All resolutions passed with over 99% approval from voting members.
👀 What to Watch
The structured leadership transition and board strengthening are positive indicators of long-term planning and governance. Investors should view this as a sign of stability and continuity in the company's strategic direction.
Clean Science Shareholders Approve MD Succession and New Board Appointments
Clean Science and Technology Limited has received shareholder approval for a significant leadership transition effective April 1, 2026. Mr. Siddhartha Ashok Sikchi will be elevated to Managing Director for a five-year term, while the current MD, Mr. Ashok Ramnarayan Boob, will transition to Executive Vice Chairman. Additionally, shareholders approved the appointment and re-appointment of four Independent Directors, ensuring board stability. All resolutions were passed with overwhelming majorities, often exceeding 99% of the votes cast, indicating strong institutional and promoter support.
Key Highlights
Mr. Siddhartha Ashok Sikchi appointed as Managing Director for a 5-year term starting April 1, 2026.
Current MD Mr. Ashok Ramnarayan Boob to transition to Executive Vice Chairman from April 2026 to July 2027.
Mr. Keval Navinchandra Doshi re-appointed as Independent Director for 5 years with 99.46% favorable votes.
New Independent Directors Mr. Raj Kamal and Ms. Pallavi Gokhale appointed for 5-year terms starting November 2025.
All six resolutions passed with requisite majority via postal ballot involving 2,49,493 members.
👀 What to Watch
Investors should view the structured succession plan and board strengthening as a positive indicator of corporate governance and long-term stability. No immediate action is required as the transition is well-planned for 2026.
